Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacillus mesentericus is a spore-forming, Gram-positive bacterium commonly found in soil, water, and the gastrointestinal tracts of animals. It is primarily used as a probiotic supplement to promote gastrointestinal health. As a probiotic, Bacillus mesentericus helps restore and maintain the balance of beneficial bacteria in the gut, supports digestion by regulating abnormal bowel movements, and enhances immune function. It may also exhibit antimicrobial properties against certain pathogens. Clinical uses include management of antibiotic-associated diarrhea, infectious diarrhea, gastroenteritis, inflammatory bowel disease (IBD), constipation, Clostridium difficile-associated diarrhea, irritable bowel syndrome (IBS), Helicobacter pylori infection, traveler’s diarrhea, lactose intolerance symptoms relief in some patients with chronic constipation or other GI disturbances[1][4][8]. The mechanism involves inhibition of pathogenic bacterial growth and support for healthy intestinal microflora.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bacillus mesentericus.